Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-9-11
|
pubmed:abstractText |
SD rats bearing acetoxymethylmethylnitrosamine-induced colorectal carcinomas were treated by i.v. administration of trans-imidazolium-bisimidazoletetrachlororuthenate (III) ImH(RuIm2Cl4), bisbenzimidazolium-benzimidazolepentachlororuthenate (III) (BzImH)2(RuBzImCl5) and trans-indazolium-bisindazoletetrachlororuthenate (III) In-dH(ruInd2Cl4). The dose levels used were 0.022 mmol/kg body weight administered twice weekly over ten weeks for all compounds and, additionally, 0.015 mmol/kg for ImH(RuIm2Cl4). All compounds caused a tumor growth inhibition exceeding 90%; differences were found with regard to toxicity: ImH(RuIm2Cl4 and (BzImH)2(RuBzImCl5) caused dose-related decreases in body weight and increases in mortality as shown by 21% and 29% body weight loss compared to controls as well as 10% and 45% mortality for the two dosages of the first compound, and 9% body weight loss compared to controls as well as 7% mortality for the latter compound. In contrast, equimolar administration of IndH(RuInd2Cl4) was not related to any symptoms of toxicity as evidenced by 2% body weight gain compared to controls as well as 0% mortality. Since this latter drug obviously showed remarkable activity in a highly resistant type of tumor at negligible toxicity, it certainly deserves special attention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Ruthenium,
http://linkedlifedata.com/resource/pubmed/chemical/imidazolium-bis(imidazole)tetrachlor...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
761-5
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2764521-Animals,
pubmed-meshheading:2764521-Antineoplastic Agents,
pubmed-meshheading:2764521-Body Weight,
pubmed-meshheading:2764521-Colorectal Neoplasms,
pubmed-meshheading:2764521-Imidazoles,
pubmed-meshheading:2764521-Male,
pubmed-meshheading:2764521-Organometallic Compounds,
pubmed-meshheading:2764521-Rats,
pubmed-meshheading:2764521-Rats, Inbred Strains,
pubmed-meshheading:2764521-Ruthenium,
pubmed-meshheading:2764521-Structure-Activity Relationship
|
pubmed:articleTitle |
Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats.
|
pubmed:affiliation |
Institute of Toxicology and Chemotherapy, German Cancer Research Center, F.R.G.
|
pubmed:publicationType |
Journal Article
|